LATE-NC risk alleles (in TMEM106B, GRN, and ABCC9 genes) among persons with African ancestry
暂无分享,去创建一个
[1] C. DeCarli,et al. TDP-43 Pathology in the Setting of Intermediate and High Alzheimer's Disease Neuropathologic Changes: A Preliminary Evaluation Across Ethnoracial Groups. , 2023, Journal of Alzheimer's disease : JAD.
[2] Janna H. Neltner,et al. LATE-NC staging in routine neuropathologic diagnosis: an update , 2022, Acta Neuropathologica.
[3] R. Buchert,et al. Differential diagnosis of amnestic dementia patients based on an FDG-PET signature of autopsy-confirmed LATE-NC , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[4] Caitlin P. McHugh,et al. Recommendations on the use and reporting of race, ethnicity, and ancestry in genetic research: Experiences from the NHLBI TOPMed program , 2022, Cell genomics.
[5] Janna H. Neltner,et al. Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts , 2022, Acta Neuropathologica.
[6] J. Masdeu,et al. Patterns of amygdala region pathology in LATE-NC: subtypes that differ with regard to TDP-43 histopathology, genetic risk factors, and comorbid pathologies , 2022, Acta Neuropathologica.
[7] C. Ferri,et al. Attenuated effect of the apolipoprotein E ɛ4 allele on neuropsychiatric symptoms among African older adults , 2021, International Psychogeriatrics.
[8] Kevin L. Boehme,et al. Distinct clinicopathologic clusters of persons with TDP-43 proteinopathy , 2020, Acta Neuropathologica.
[9] D. Bennett,et al. Limbic-predominant age-related TDP-43 encephalopathy in Black and White decedents , 2020, Neurology.
[10] T. A. Alexander,et al. LDpop: an interactive online tool to calculate and visualize geographic LD patterns , 2020, BMC Bioinformatics.
[11] Alex Diaz-Papkovich,et al. UMAP reveals cryptic population structure and phenotype heterogeneity in large genomic cohorts , 2019, PLoS genetics.
[12] C. Jack,et al. Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report , 2019, Brain : a journal of neurology.
[13] C. DeCarli,et al. Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center. , 2019, Journal of Alzheimer's Disease.
[14] Brian E. Cade,et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program , 2019, Nature.
[15] Kevin F. Bieniek,et al. Ethnoracial differences in Alzheimer’s disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort , 2019, Alzheimer's & Dementia.
[16] Charles C. White,et al. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study , 2018, The Lancet Neurology.
[17] Y. Asmann,et al. TMEM106B haplotypes have distinct gene expression patterns in aged brain , 2018, Molecular Neurodegeneration.
[18] Clifford R. Jack,et al. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable , 2018, Alzheimer's & Dementia.
[19] Sally R. Ellingson,et al. Gene-based association study of genes linked to hippocampal sclerosis of aging neuropathology: GRN, TMEM106B, ABCC9, and KCNMB2 , 2017, Neurobiology of Aging.
[20] D. Bennett,et al. Genetic architecture of age-related cognitive decline in African Americans , 2016, Neurology: Genetics.
[21] Derek J Van Booven,et al. ABCA7 frameshift deletion associated with Alzheimer disease in African Americans , 2016, Neurology: Genetics.
[22] Kevin L. Boehme,et al. Assessment of the genetic variance of late-onset Alzheimer's disease , 2016, Neurobiology of Aging.
[23] L. Grinberg,et al. Higher Prevalence of TDP‐43 Proteinopathy in Cognitively Normal Asians: A Clinicopathological Study on a Multiethnic Sample , 2016, Brain pathology.
[24] Timothy J. Hohman,et al. Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk , 2016, Alzheimer's & Dementia.
[25] Mitchell J. Machiela,et al. LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..
[26] S. Leurgans,et al. Hippocampal sclerosis and TDP‐43 pathology in aging and Alzheimer disease , 2015, Annals of neurology.
[27] David Reich,et al. The Genetic Ancestry of African Americans, Latinos, and European Americans across the United States , 2015, American journal of human genetics.
[28] Carson C Chow,et al. Second-generation PLINK: rising to the challenge of larger and richer datasets , 2014, GigaScience.
[29] Margaret A. Pericak-Vance,et al. Genome-Wide Association Meta-analysis of Neuropathologic Features of Alzheimer's Disease and Related Dementias , 2014, PLoS genetics.
[30] M. Murray,et al. Differential clinicopathologic and genetic features of late-onset amnestic dementias , 2014, Acta Neuropathologica.
[31] Charles D. Smith,et al. ABCC9 gene polymorphism is associated with hippocampal sclerosis of aging pathology , 2014, Acta Neuropathologica.
[32] P. Crane,et al. Alzheimer’s Disease: Analyzing the Missing Heritability , 2013, PloS one.
[33] Christine Haberler,et al. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series , 2013, Acta Neuropathologica.
[34] Oscar L Lopez,et al. Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. , 2013, JAMA.
[35] Iuliana Ionita-Laza,et al. Scan-statistic approach identifies clusters of rare disease variants in LRP2, a gene linked and associated with autism spectrum disorders, in three datasets. , 2012, American journal of human genetics.
[36] L. Grinberg,et al. African ancestry protects against Alzheimer's disease-related neuropathology , 2011, Molecular Psychiatry.
[37] P. Sham,et al. Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases , 2011, Genetic epidemiology.
[38] L. Park. Identifying disease polymorphisms from case–control genetic association data , 2010, Genetica.
[39] D. Dickson,et al. Common Variant in GRN Is a Genetic Risk Factor for Hippocampal Sclerosis in the Elderly , 2010, Neurodegenerative Diseases.
[40] Charles D. Smith,et al. Modeling the Association between 43 Different Clinical and Pathological Variables and the Severity of Cognitive Impairment in a Large Autopsy Cohort of Elderly Persons , 2010, Brain pathology.
[41] R. Petersen,et al. Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia , 2008, Human molecular genetics.
[42] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[43] D. Dickson,et al. TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease , 2007, Annals of neurology.
[44] H. Braak,et al. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry , 2006, Acta Neuropathologica.
[45] J. Ott,et al. Power and Sample Size Calculations for Case-Control Genetic Association Tests when Errors Are Present: Application to Single Nucleotide Polymorphisms , 2002, Human Heredity.
[46] H. Braak,et al. Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.
[47] R. Green,et al. Risk of dementia among white and African American relatives of patients with Alzheimer disease. , 2002, JAMA.
[48] O. Gureje,et al. Apolipoprotein E—associated risk for Alzheimer's disease in the African‐American population is genotype dependent , 1997, Annals of neurology.
[49] S. M. Sumi,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.
[50] F. Schmitt,et al. Challenges and Considerations Related to Studying Dementia in Blacks/African Americans. , 2017, Journal of Alzheimer's disease : JAD.
[51] M. Murray,et al. Hippocampal sclerosis in Lewy body disease is a TDP-43 proteinopathy similar to FTLD-TDP Type A , 2014, Acta Neuropathologica.
[52] Charles Duyckaerts,et al. National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach , 2011, Acta Neuropathologica.
[53] D. Selkoe. Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.